Literature DB >> 27885531

Evolution of Liver Steatosis Quantified by MR Imaging and MR Spectroscopy, in Morbidly Obese Patients Undergoing Sleeve Gastrectomy: Short-Term Outcomes.

María Engracia Alsina1, Jaime Ruiz-Tovar2, Angela Bernabeu3.   

Abstract

BACKGROUND: Currently, the standard procedure used to evaluate hepatic steatosis is the liver biopsy. This is an invasive practice that presents inherent risks. Increasing evidence suggests that magnetic resonance imaging (MRI) and MR spectroscopy (MRS) may represent an accurate method to determine the hepatic lipid content. The aim of this study was to evaluate the effect of sleeve gastrectomy on liver steatosis, quantified by MRI and MRS. PATIENTS AND METHODS: A prospective observational study of patients undergoing laparoscopic sleeve gastrectomy was performed. All patients underwent a MRI and a MRS study 2 weeks before the intervention and 6 months after the surgery. Anthropometric, biochemical, and radiological parameters were analyzed.
RESULTS: Twenty-three patients were included, 21 females and 2 males, with a mean age of 47.6 ± 10.6 years and mean pre-op BMI 47.6 ± 6.7 Kg/m2. Six months after surgery, mean BMI was 32.2 ± 5.1 Kg/m2, with a mean excess weight loss of 68.2 ± 18.6%. Mean preoperative hepatic volume was 1999.9 ± 436.2 ml and 6 months after surgery it decreased to 1568 ± 170.3 ml (p = 0.005). Mean preoperative percentage of lipid content was 14.2 ± 15.4% and 6 months after surgery, it decreased to 4.3 ± 3.2% (p = 0.007). A significant reduction of steatosis grade was observed, with disappearance of preoperative steatosis in 54.9% of the patients.
CONCLUSION: Six months after sleeve gastrectomy, a significant reduction of liver steatosis is observed, as demonstrated by reduction in the percentage of intrahepatocitary lipids and liver volume, determined by MRS and MRI. These imaging techniques can be considered as noninvasive, accurate methods for monitoring liver steatosis in morbidly obese patients undergoing bariatric surgery.

Entities:  

Keywords:  Liver steatosis; Magnetic resonance imaging; Sleeve gastrectomy; Spectroscopy

Mesh:

Year:  2017        PMID: 27885531     DOI: 10.1007/s11695-016-2473-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  32 in total

1.  Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients.

Authors:  Chi-Ming Tai; Chih-Kun Huang; Jau-Chung Hwang; Hung Chiang; Chi-Yang Chang; Ching-Tai Lee; Ming-Lung Yu; Jaw-Town Lin
Journal:  Obes Surg       Date:  2012-07       Impact factor: 4.129

2.  Measurement of liver fat by magnetic resonance imaging: Relationships with body fat distribution, insulin sensitivity and plasma lipids in healthy men.

Authors:  D C Chan; G F Watts; T W K Ng; J Hua; S Song; P H R Barrett
Journal:  Diabetes Obes Metab       Date:  2006-11       Impact factor: 6.577

3.  Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.

Authors:  John B Dixon; Prithi S Bhathal; Paul E O'Brien
Journal:  Obes Surg       Date:  2006-10       Impact factor: 4.129

4.  Liver disease in the morbidly obese: a review of 1000 consecutive patients undergoing weight loss surgery.

Authors:  Michael Subichin; Jesse Clanton; Marta Makuszewski; Ashley Bohon; John G Zografakis; Adrian Dan
Journal:  Surg Obes Relat Dis       Date:  2014-07-03       Impact factor: 4.734

5.  Midterm impact of sleeve gastrectomy, calibrated with a 50-Fr bougie, on weight loss, glucose homeostasis, lipid profiles, and comorbidities in morbidly obese patients.

Authors:  Jaime Ruiz-Tovar; Inmaculada Oller; Andres Tomas; Carolina Llavero; Antonio Arroyo; Alicia Calero; Amparo Martinez-Blasco; Rafael Calpena
Journal:  Am Surg       Date:  2012-09       Impact factor: 0.688

6.  Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy.

Authors:  Boris Guiu; Jean-Michel Petit; Romaric Loffroy; Douraied Ben Salem; Serge Aho; David Masson; Patrick Hillon; Denis Krause; Jean-Pierre Cercueil
Journal:  Radiology       Date:  2009-01       Impact factor: 11.105

Review 7.  Imaging-based quantification of hepatic fat: methods and clinical applications.

Authors:  Xiaozhou Ma; Nagaraj-Setty Holalkere; Avinash Kambadakone R; Mari Mino-Kenudson; Peter F Hahn; Dushyant V Sahani
Journal:  Radiographics       Date:  2009 Sep-Oct       Impact factor: 5.333

8.  Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.

Authors:  Z M Younossi; T Gramlich; Y C Liu; C Matteoni; M Petrelli; J Goldblum; L Rybicki; A J McCullough
Journal:  Mod Pathol       Date:  1998-06       Impact factor: 7.842

9.  Nonalcoholic fatty liver disease: diagnosis and management.

Authors:  Thad Wilkins; Altaf Tadkod; Iryna Hepburn; Robert R Schade
Journal:  Am Fam Physician       Date:  2013-07-01       Impact factor: 3.292

10.  Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study.

Authors:  E L Thomas; G Hamilton; N Patel; R O'Dwyer; C J Doré; R D Goldin; J D Bell; S D Taylor-Robinson
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

View more
  2 in total

Review 1.  How to best assess abdominal obesity.

Authors:  Hongjuan Fang; Elizabeth Berg; Xiaoguang Cheng; Wei Shen
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2018-09       Impact factor: 4.294

Review 2.  Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis.

Authors:  Miller Barreto de Brito E Silva; Francisco Tustumi; Antonio Afonso de Miranda Neto; Anna Carolina Batista Dantas; Marco Aurélio Santo; Ivan Cecconello
Journal:  Obes Surg       Date:  2021-04-13       Impact factor: 4.129

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.